Divergent targets of glycolysis and oxidative phosphorylation result in additive effects of metformin and starvation in colon and breast cancer

Cecilia Marini, Giovanna Bianchi, Ambra Buschiazzo, Silvia Ravera, Roberto Martella, Gianluca Bottoni, Andrea Petretto, Laura Emionite, Elena Monteverde, Selene Capitanio, Elvira Inglese, Marina Fabbi, Francesca Bongioanni, Lucia Garaboldi, Paolo Bruzzi, Anna Maria Orengo, Lizzia Raffaghello, Gianmario Sambuceti

Research output: Contribution to journalArticle

Abstract

Emerging evidence demonstrates that targeting energy metabolism is a promising strategy to fight cancer. Here we show that combining metformin and short-term starvation markedly impairs metabolism and growth of colon and breast cancer. The impairment in glycolytic flux caused by starvation is enhanced by metformin through its interference with hexokinase II activity, as documented by measurement of 18F-fluorodeoxyglycose uptake. Oxidative phosphorylation is additively compromised by combined treatment: metformin virtually abolishes Complex I function; starvation determines an uncoupled status of OXPHOS and amplifies the activity of respiratory Complexes II and IV thus combining a massive ATP depletion with a significant increase in reactive oxygen species. More importantly, the combined treatment profoundly impairs cancer glucose metabolism and virtually abolishes lesion growth in experimental models of breast and colon carcinoma. Our results strongly suggest that energy metabolism is a promising target to reduce cancer progression.

Original languageEnglish
Article number19569
JournalScientific Reports
Volume6
DOIs
Publication statusPublished - Jan 22 2016

Fingerprint

Metformin
Oxidative Phosphorylation
Glycolysis
Starvation
Colonic Neoplasms
Breast Neoplasms
Energy Metabolism
Neoplasms
Hexokinase
Growth
Reactive Oxygen Species
Colon
Theoretical Models
Adenosine Triphosphate
Glucose

ASJC Scopus subject areas

  • General

Cite this

Divergent targets of glycolysis and oxidative phosphorylation result in additive effects of metformin and starvation in colon and breast cancer. / Marini, Cecilia; Bianchi, Giovanna; Buschiazzo, Ambra; Ravera, Silvia; Martella, Roberto; Bottoni, Gianluca; Petretto, Andrea; Emionite, Laura; Monteverde, Elena; Capitanio, Selene; Inglese, Elvira; Fabbi, Marina; Bongioanni, Francesca; Garaboldi, Lucia; Bruzzi, Paolo; Orengo, Anna Maria; Raffaghello, Lizzia; Sambuceti, Gianmario.

In: Scientific Reports, Vol. 6, 19569, 22.01.2016.

Research output: Contribution to journalArticle

Marini, Cecilia ; Bianchi, Giovanna ; Buschiazzo, Ambra ; Ravera, Silvia ; Martella, Roberto ; Bottoni, Gianluca ; Petretto, Andrea ; Emionite, Laura ; Monteverde, Elena ; Capitanio, Selene ; Inglese, Elvira ; Fabbi, Marina ; Bongioanni, Francesca ; Garaboldi, Lucia ; Bruzzi, Paolo ; Orengo, Anna Maria ; Raffaghello, Lizzia ; Sambuceti, Gianmario. / Divergent targets of glycolysis and oxidative phosphorylation result in additive effects of metformin and starvation in colon and breast cancer. In: Scientific Reports. 2016 ; Vol. 6.
@article{fcce730889c44846b811b89b7149e226,
title = "Divergent targets of glycolysis and oxidative phosphorylation result in additive effects of metformin and starvation in colon and breast cancer",
abstract = "Emerging evidence demonstrates that targeting energy metabolism is a promising strategy to fight cancer. Here we show that combining metformin and short-term starvation markedly impairs metabolism and growth of colon and breast cancer. The impairment in glycolytic flux caused by starvation is enhanced by metformin through its interference with hexokinase II activity, as documented by measurement of 18F-fluorodeoxyglycose uptake. Oxidative phosphorylation is additively compromised by combined treatment: metformin virtually abolishes Complex I function; starvation determines an uncoupled status of OXPHOS and amplifies the activity of respiratory Complexes II and IV thus combining a massive ATP depletion with a significant increase in reactive oxygen species. More importantly, the combined treatment profoundly impairs cancer glucose metabolism and virtually abolishes lesion growth in experimental models of breast and colon carcinoma. Our results strongly suggest that energy metabolism is a promising target to reduce cancer progression.",
author = "Cecilia Marini and Giovanna Bianchi and Ambra Buschiazzo and Silvia Ravera and Roberto Martella and Gianluca Bottoni and Andrea Petretto and Laura Emionite and Elena Monteverde and Selene Capitanio and Elvira Inglese and Marina Fabbi and Francesca Bongioanni and Lucia Garaboldi and Paolo Bruzzi and Orengo, {Anna Maria} and Lizzia Raffaghello and Gianmario Sambuceti",
year = "2016",
month = "1",
day = "22",
doi = "10.1038/srep19569",
language = "English",
volume = "6",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Divergent targets of glycolysis and oxidative phosphorylation result in additive effects of metformin and starvation in colon and breast cancer

AU - Marini, Cecilia

AU - Bianchi, Giovanna

AU - Buschiazzo, Ambra

AU - Ravera, Silvia

AU - Martella, Roberto

AU - Bottoni, Gianluca

AU - Petretto, Andrea

AU - Emionite, Laura

AU - Monteverde, Elena

AU - Capitanio, Selene

AU - Inglese, Elvira

AU - Fabbi, Marina

AU - Bongioanni, Francesca

AU - Garaboldi, Lucia

AU - Bruzzi, Paolo

AU - Orengo, Anna Maria

AU - Raffaghello, Lizzia

AU - Sambuceti, Gianmario

PY - 2016/1/22

Y1 - 2016/1/22

N2 - Emerging evidence demonstrates that targeting energy metabolism is a promising strategy to fight cancer. Here we show that combining metformin and short-term starvation markedly impairs metabolism and growth of colon and breast cancer. The impairment in glycolytic flux caused by starvation is enhanced by metformin through its interference with hexokinase II activity, as documented by measurement of 18F-fluorodeoxyglycose uptake. Oxidative phosphorylation is additively compromised by combined treatment: metformin virtually abolishes Complex I function; starvation determines an uncoupled status of OXPHOS and amplifies the activity of respiratory Complexes II and IV thus combining a massive ATP depletion with a significant increase in reactive oxygen species. More importantly, the combined treatment profoundly impairs cancer glucose metabolism and virtually abolishes lesion growth in experimental models of breast and colon carcinoma. Our results strongly suggest that energy metabolism is a promising target to reduce cancer progression.

AB - Emerging evidence demonstrates that targeting energy metabolism is a promising strategy to fight cancer. Here we show that combining metformin and short-term starvation markedly impairs metabolism and growth of colon and breast cancer. The impairment in glycolytic flux caused by starvation is enhanced by metformin through its interference with hexokinase II activity, as documented by measurement of 18F-fluorodeoxyglycose uptake. Oxidative phosphorylation is additively compromised by combined treatment: metformin virtually abolishes Complex I function; starvation determines an uncoupled status of OXPHOS and amplifies the activity of respiratory Complexes II and IV thus combining a massive ATP depletion with a significant increase in reactive oxygen species. More importantly, the combined treatment profoundly impairs cancer glucose metabolism and virtually abolishes lesion growth in experimental models of breast and colon carcinoma. Our results strongly suggest that energy metabolism is a promising target to reduce cancer progression.

UR - http://www.scopus.com/inward/record.url?scp=84955443998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955443998&partnerID=8YFLogxK

U2 - 10.1038/srep19569

DO - 10.1038/srep19569

M3 - Article

VL - 6

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 19569

ER -